🇺🇸 FDA
Patent

US 11065254

Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections

granted A61KA61K31/4045A61K31/513

Quick answer

US patent 11065254 (Antiviral JAK inhibitors useful in treating or preventing retroviral and other viral infections) held by United States Government as represented by the Department of Veterans Affairs expires Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
United States Government as represented by the Department of Veterans Affairs
Grant date
Tue Jul 20 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jul 15 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K31/4045, A61K31/513, A61K31/519, A61K31/52